Statement by investee company

Cater Barnard PLC
10 March 2003


FOR IMMEDIATE RELEASE                                             10 March 2003

              CATER BARNARD PLC ('Cater Barnard' or 'the Company')


The following is the text of an announcement issued by Dialog Group, Inc in
which Cater Barnard has a fully diluted 25% interest:

'Dialog Group, Inc. Merges with HealthCare Dialog and Acquires IP2M


NEW YORK - March 10, 2003 - Dialog Group, Inc. (OTC Bulletin Board: DLGG),
announced today that it has completed its merger with HealthCare Dialog and its
acquisition of IP2M.

Highlights:


      • 50/50 merger with HealthCare Dialog increases revenue by over $4
        million and adds positively to the bottom line.

      • IP2M acquisition for 10% of the post merged company increases revenue
        by over $2 million and adds valuable synergies for significant growth.

      • Conversion of over $2 million in debt by the company's largest
        investor, Cater Barnard, strengthens the balance sheet and continues to
        demonstrate Cater Barnard's strong support.

      • Peter DeCrescenzo, new CEO of the Dialog Group, and Robin Smith, MD,
        head of IP2M, provide a history of successes and experiences that can
        build the business and shareholder value.



Peter DeCrescenzo, CEO of Dialog Group commented: 'This merger and acquisition
further solidifies Dialog Group's commitment towards building a premier
marketing and sales organization, bringing together a stronger and broader
client roster, expanded core capabilities in sales and marketing, comprehensive
product offerings, cross-platform synergies and improved operational
efficiencies.'

Robin Smith, MD, added: 'The convergence of companies and management creates an
exiting opportunity for our clients in that the expanded breath of services
provides additional channels for our clients to reach their consumers.'



About Healthcare Dialog:

Healthcare Dialog, Inc. is a New York based leading provider of relationship
marketing communications services to the healthcare industry. Current and past
clients include: Novartis AG; Schering-Plough Corp.; GlaxoSmithKline;
Boehringer-Ingelheim; Forest Laboratories; and Acurian. Healthcare Dialog
provides healthcare clients with a targeted marketing and campaign management
solutions aimed at finding, attracting and retaining customers.




About IP2M:

IP2M is a Houston based provider of enabling technologies to websites, merchants
and wireless devices that enables the channeling of advertising, sponsorships,
website multimedia content, directory services and e-commerce through IP2M's
technology platform and affiliate networks. IP2M's primary affiliates are media
conglomerates that have networks of websites throughout the U.S. that promote
distribution of information on both a localized and demographic basis. IP2M has
relationships with Clear Channel Communications, Nassau Broadcasting, ABC Radio,
Hispanic Broadcasting, and through Internet Broadcast Systems Hearst-Argyle
Television, McGraw-Hill Television, Granite and Post-Newsweek Television. IP2M's
technology, services and networks afford business solutions to companies by
providing a truly integrated platform to market.

About Dialog Group:

Dialog Group is a provider of relationship marketing communications services,
business and consumer targeting databases for the healthcare, financial, and
other direct-to-consumer business markets.



-----------------------------------

This press release contains 'forward-looking statements' within the meaning of
the Safe Harbor Provisions of the Private Securities Litigation Reform Act of
1995. These statements are not historical facts but instead represent only the
firm's belief regarding future events, many of which, by their nature, are
inherently uncertain and outside of the firm's control. It is possible that the
firm's actual results and financial condition may differ, possibly materially,
from the anticipated results and financial condition indicated in these
forward-looking statements. The Company does not undertake, and specifically
disclaims, any obligation to publicly release the results of any revisions,
which may be made to any forward-looking statements to reflect the occurrence of
anticipated or unanticipated events or circumstances after the date of such
forward-looking statements. For a discussion of some of the risks and important
factors that could affect the firm's future results, see the Company's reports
that are filed and available through the Securities and Exchange Commission's
Electronic Data Gathering Analysis and Retrieval system (EDGAR) at http://
www.sec.gov.

----------------------------

For more information please contact: Dialog Group, Inc.

Adrian Stecyk, [phone]'


                      This information is provided by RNS
            The company news service from the London Stock Exchange